1. Home
  2. CCCC vs FC Comparison

CCCC vs FC Comparison

Compare CCCC & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Logo Franklin Covey Company

FC

Franklin Covey Company

HOLD

Current Price

$16.88

Market Cap

193.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
FC
Founded
2015
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
240.3M
193.2M
IPO Year
2020
1992

Fundamental Metrics

Financial Performance
Metric
CCCC
FC
Price
$1.89
$16.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$7.25
$24.50
AVG Volume (30 Days)
1.9M
124.2K
Earning Date
11-06-2025
01-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.24
Revenue
$30,108,000.00
$267,067,000.00
Revenue This Year
N/A
$2.82
Revenue Next Year
N/A
$4.35
P/E Ratio
N/A
$70.70
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$14.04
52 Week High
$4.26
$39.22

Technical Indicators

Market Signals
Indicator
CCCC
FC
Relative Strength Index (RSI) 32.78 53.67
Support Level $1.93 $16.63
Resistance Level $2.13 $17.48
Average True Range (ATR) 0.12 0.47
MACD -0.03 0.02
Stochastic Oscillator 0.00 51.33

Price Performance

Historical Comparison
CCCC
FC

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

Share on Social Networks: